Attached files
file | filename |
---|---|
EX-32.2 - EXHIBIT 32.2 - Fortress Biotech, Inc. | tm205350d1_ex32-2.htm |
EX-32.1 - EXHIBIT 32.1 - Fortress Biotech, Inc. | tm205350d1_ex32-1.htm |
EX-31.2 - EXHIBIT 31.2 - Fortress Biotech, Inc. | tm205350d1_ex31-2.htm |
EX-31.1 - EXHIBIT 31.1 - Fortress Biotech, Inc. | tm205350d1_ex31-1.htm |
EX-23.1 - EXHIBIT 23.1 - Fortress Biotech, Inc. | tm205350d1_ex23-1.htm |
EX-4.3 - EXHIBIT 4.3 - Fortress Biotech, Inc. | tm205350d1_ex4-3.htm |
10-K - FORM 10-K - Fortress Biotech, Inc. | tm205350d1_10k.htm |
EXHIBIT 21.1
SUBSIDIARIES OF FORTRESS BIOTECH, INC.
Subsidiaries of Fortress Biotech, Inc. at December 31, 2019, with jurisdiction of incorporation or formation:
• | Aevitas Therapeutics, Inc. (Delaware) | |
• | Avenue Therapeutics, Inc. (Delaware) | |
• | Baergic Bio, Inc. (Delaware) | |
• | Caelum Biosciences, Inc. (Delaware), formerly FBIO Acquisition Corp. II | |
• | Cellvation, Inc. (Delaware), formerly FBIO Acquisition Corp. I | |
• | Checkpoint Therapeutics, Inc. (Delaware) | |
• | Cyprium Therapeutics, Inc. (Delaware) | |
• | Helocyte, Inc. (Delaware), formerly DiaVax Biosciences, Inc. | |
Hepla Sciences, Inc. (Delaware), formerly FBIO Acquisition Corp. IV | ||
• | Journey Medical Corporation (Delaware) | |
• | Mustang Bio, Inc. (Delaware) | |
Oncogenuity, Inc. (Delaware), formerly FBIO Acquisition Corp. VI | ||
• | CB Securities Corporation (Massachusetts) | |
• | Coronado SO Co. (Delaware) | |
• | Escala Therapeutics, Inc., formerly Altamira Biosciences, Inc. (Delaware) | |
• | FBIO Acquisition Corps. VI – XIV (Delaware) | |
• | Fortress Biotech, China, Inc. | |
• | Innmune Limited (United Kingdom) | |
• | Tamid Bio, Inc. (Delaware) | |